[
  {
    "company": "Black Diamond Therapeutics",
    "ticker": "BDTX",
    "date": "2020-01-30",
    "offer": 19.0,
    "proceeds": 201.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10580000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "PPD Inc",
    "ticker": "PPD",
    "date": "2020-02-05",
    "offer": 27.0,
    "proceeds": 1800.0,
    "year": 2020,
    "area": "CRO/Services",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 66670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Schrodinger",
    "ticker": "SDGR",
    "date": "2020-02-05",
    "offer": 17.0,
    "proceeds": 232.0,
    "year": 2020,
    "area": "Computational",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13650000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Beam Therapeutics",
    "ticker": "BEAM",
    "date": "2020-02-06",
    "offer": 17.0,
    "proceeds": 180.0,
    "year": 2020,
    "area": "Gene Editing",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10590000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Revolution Medicines",
    "ticker": "RVMD",
    "date": "2020-02-12",
    "offer": 17.0,
    "proceeds": 238.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 14000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Passage Bio",
    "ticker": "PASG",
    "date": "2020-02-27",
    "offer": 18.0,
    "proceeds": 216.0,
    "year": 2020,
    "area": "Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zentalis Pharmaceuticals",
    "ticker": "ZNTL",
    "date": "2020-04-02",
    "offer": 18.0,
    "proceeds": 165.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9170000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "ORIC Pharmaceuticals",
    "ticker": "ORIC",
    "date": "2020-04-23",
    "offer": 16.0,
    "proceeds": 120.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Panbela Therapeutics",
    "ticker": "PBLA",
    "date": "2020-06-03",
    "offer": 6.0,
    "proceeds": 12.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Legend Biotech",
    "ticker": "LEGN",
    "date": "2020-06-05",
    "offer": 23.0,
    "proceeds": 487.34,
    "year": 2020,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 21190000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Generation Bio",
    "ticker": "GBIO",
    "date": "2020-06-11",
    "offer": 20.0,
    "proceeds": 230.0,
    "year": 2020,
    "area": "Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Royalty Pharma",
    "ticker": "RPRX",
    "date": "2020-06-15",
    "offer": 28.0,
    "proceeds": 2200.0,
    "year": 2020,
    "area": "Royalties/Diversified",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 78570000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "ALX Oncology",
    "ticker": "ALXO",
    "date": "2020-06-18",
    "offer": 19.0,
    "proceeds": 161.5,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Forma Therapeutics",
    "ticker": "FMTX",
    "date": "2020-06-18",
    "offer": 20.0,
    "proceeds": 319.0,
    "year": 2020,
    "area": "Hematology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15950000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nkarta Therapeutics",
    "ticker": "NKTX",
    "date": "2020-06-18",
    "offer": 18.0,
    "proceeds": 193.5,
    "year": 2020,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Repare Therapeutics",
    "ticker": "RPTX",
    "date": "2020-06-18",
    "offer": 18.0,
    "proceeds": 160.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8890000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Compass Therapeutics",
    "ticker": "CMPX",
    "date": "2020-06-25",
    "offer": 17.0,
    "proceeds": 188.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11060000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Imago BioSciences",
    "ticker": "IMGO",
    "date": "2020-07-15",
    "offer": 16.0,
    "proceeds": 96.0,
    "year": 2020,
    "area": "Hematology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Erasca",
    "ticker": "ERAS",
    "date": "2020-07-15",
    "offer": 16.0,
    "proceeds": 244.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Relay Therapeutics",
    "ticker": "RLAY",
    "date": "2020-07-16",
    "offer": 20.0,
    "proceeds": 400.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 20000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Berkeley Lights",
    "ticker": "BLI",
    "date": "2020-07-16",
    "offer": 22.0,
    "proceeds": 178.2,
    "year": 2020,
    "area": "Platforms",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8100000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Pandion Therapeutics",
    "ticker": "PAND",
    "date": "2020-07-16",
    "offer": 18.0,
    "proceeds": 135.0,
    "year": 2020,
    "area": "Autoimmune",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Annexon Biosciences",
    "ticker": "ANNX",
    "date": "2020-07-23",
    "offer": 17.0,
    "proceeds": 120.0,
    "year": 2020,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7060000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "iTeos Therapeutics",
    "ticker": "ITOS",
    "date": "2020-07-23",
    "offer": 20.0,
    "proceeds": 201.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10050000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AlloVir",
    "ticker": "ALVR",
    "date": "2020-07-30",
    "offer": 17.0,
    "proceeds": 276.0,
    "year": 2020,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 16239999,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Tarsus Pharmaceuticals",
    "ticker": "TARS",
    "date": "2020-08-06",
    "offer": 15.0,
    "proceeds": 84.0,
    "year": 2020,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CureVac",
    "ticker": "CVAC",
    "date": "2020-08-14",
    "offer": 16.0,
    "proceeds": 213.3,
    "year": 2020,
    "area": "mRNA/Vaccines",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Inhibrx",
    "ticker": "INBX",
    "date": "2020-08-18",
    "offer": 17.0,
    "proceeds": 126.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7410000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kymera Therapeutics",
    "ticker": "KYMR",
    "date": "2020-08-20",
    "offer": 20.0,
    "proceeds": 173.3,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "PMV Pharmaceuticals",
    "ticker": "PMVP",
    "date": "2020-09-24",
    "offer": 18.0,
    "proceeds": 173.8,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9660000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Prelude Therapeutics",
    "ticker": "PRTX",
    "date": "2020-09-24",
    "offer": 26.0,
    "proceeds": 200.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7690000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Gritstone bio",
    "ticker": "GRTS",
    "date": "2020-10-01",
    "offer": 17.0,
    "proceeds": 129.0,
    "year": 2020,
    "area": "Oncology/Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7590000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Praxis Precision Medicine",
    "ticker": "PRAX",
    "date": "2020-10-15",
    "offer": 19.0,
    "proceeds": 233.4,
    "year": 2020,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12280000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Atea Pharmaceuticals",
    "ticker": "AVIR",
    "date": "2020-10-29",
    "offer": 24.0,
    "proceeds": 345.0,
    "year": 2020,
    "area": "Infectious Disease",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 14380000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Maravai LifeSciences",
    "ticker": "MRVI",
    "date": "2020-11-19",
    "offer": 27.0,
    "proceeds": 1860.0,
    "year": 2020,
    "area": "mRNA/Nucleic Acid",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 68890000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Olema Pharmaceuticals",
    "ticker": "OLMA",
    "date": "2020-11-19",
    "offer": 19.0,
    "proceeds": 187.5,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9870000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kinnate Biopharma",
    "ticker": "KNTE",
    "date": "2020-11-24",
    "offer": 20.0,
    "proceeds": 240.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Silverback Therapeutics",
    "ticker": "SBTX",
    "date": "2020-12-02",
    "offer": 21.0,
    "proceeds": 241.0,
    "year": 2020,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11480000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Seer Inc",
    "ticker": "SEER",
    "date": "2020-12-03",
    "offer": 19.0,
    "proceeds": 175.0,
    "year": 2020,
    "area": "Proteomics",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9210000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AbCellera Biologics",
    "ticker": "ABCL",
    "date": "2020-12-10",
    "offer": 20.0,
    "proceeds": 555.5,
    "year": 2020,
    "area": "Antibody Discovery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 27780000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Chinook Therapeutics",
    "ticker": "KDNY",
    "date": "2020-12-17",
    "offer": 17.0,
    "proceeds": 100.0,
    "year": 2020,
    "area": "Nephrology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Terns Pharmaceuticals",
    "ticker": "TERN",
    "date": "2021-01-28",
    "offer": 15.0,
    "proceeds": 95.0,
    "year": 2021,
    "area": "Metabolic/NASH",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Sana Biotechnology",
    "ticker": "SANA",
    "date": "2021-02-03",
    "offer": 25.0,
    "proceeds": 675.6,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 27020000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Vor Biopharma",
    "ticker": "VOR",
    "date": "2021-02-05",
    "offer": 18.0,
    "proceeds": 200.3,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11130000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Adagene",
    "ticker": "ADAG",
    "date": "2021-02-09",
    "offer": 19.0,
    "proceeds": 282.8,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 14880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Longeveron",
    "ticker": "LGVN",
    "date": "2021-02-12",
    "offer": 10.0,
    "proceeds": 28.2,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2820000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Instil Bio",
    "ticker": "TIL",
    "date": "2021-03-18",
    "offer": 20.0,
    "proceeds": 319.7,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15990000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Ikena Oncology",
    "ticker": "IKNA",
    "date": "2021-03-18",
    "offer": 18.0,
    "proceeds": 187.2,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10400000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Edgewise Therapeutics",
    "ticker": "EWTX",
    "date": "2021-03-25",
    "offer": 16.0,
    "proceeds": 180.0,
    "year": 2021,
    "area": "Rare Disease/Cardio",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Design Therapeutics",
    "ticker": "DSGN",
    "date": "2021-03-25",
    "offer": 20.0,
    "proceeds": 250.7,
    "year": 2021,
    "area": "Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12540000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Recursion Pharmaceuticals",
    "ticker": "RXRX",
    "date": "2021-04-15",
    "offer": 18.0,
    "proceeds": 501.8,
    "year": 2021,
    "area": "AI/Drug Discovery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 27880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Biomea Fusion",
    "ticker": "BMEA",
    "date": "2021-04-15",
    "offer": 17.0,
    "proceeds": 165.5,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9740000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zymergen",
    "ticker": "ZY",
    "date": "2021-04-21",
    "offer": 31.0,
    "proceeds": 530.0,
    "year": 2021,
    "area": "Synthetic Biology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17100000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Forte Biosciences",
    "ticker": "FBRX",
    "date": "2021-04-29",
    "offer": 14.0,
    "proceeds": 80.0,
    "year": 2021,
    "area": "Dermatology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5710000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Talaris Therapeutics",
    "ticker": "TALS",
    "date": "2021-05-06",
    "offer": 16.0,
    "proceeds": 154.1,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9630000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Vera Therapeutics",
    "ticker": "VERA",
    "date": "2021-05-14",
    "offer": 11.0,
    "proceeds": 75.0,
    "year": 2021,
    "area": "Nephrology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6820000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Achilles Therapeutics",
    "ticker": "ACHL",
    "date": "2021-05-27",
    "offer": 18.0,
    "proceeds": 176.4,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9800000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Centessa Pharmaceuticals",
    "ticker": "CNTA",
    "date": "2021-05-27",
    "offer": 20.0,
    "proceeds": 379.5,
    "year": 2021,
    "area": "Multi-asset",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 18980000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Lyell Immunopharma",
    "ticker": "LYEL",
    "date": "2021-06-16",
    "offer": 17.0,
    "proceeds": 425.0,
    "year": 2021,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 25000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Verve Therapeutics",
    "ticker": "VERV",
    "date": "2021-06-16",
    "offer": 19.0,
    "proceeds": 306.7,
    "year": 2021,
    "area": "Gene Editing/Cardio",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 16140000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "GH Research",
    "ticker": "GHRS",
    "date": "2021-06-24",
    "offer": 16.0,
    "proceeds": 160.0,
    "year": 2021,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Monte Rosa Therapeutics",
    "ticker": "GLUE",
    "date": "2021-06-24",
    "offer": 19.0,
    "proceeds": 222.7,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11720000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Elevation Oncology",
    "ticker": "ELEV",
    "date": "2021-06-24",
    "offer": 13.0,
    "proceeds": 90.0,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6920000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Rain Therapeutics",
    "ticker": "RAIN",
    "date": "2021-06-24",
    "offer": 17.0,
    "proceeds": 122.1,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7180000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Caribou Biosciences",
    "ticker": "CRBU",
    "date": "2021-07-22",
    "offer": 16.0,
    "proceeds": 304.0,
    "year": 2021,
    "area": "CRISPR/Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 19000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Absci",
    "ticker": "ABSI",
    "date": "2021-07-22",
    "offer": 16.0,
    "proceeds": 200.0,
    "year": 2021,
    "area": "Synthetic Biology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nurix Therapeutics",
    "ticker": "NRIX",
    "date": "2021-07-23",
    "offer": 19.0,
    "proceeds": 200.0,
    "year": 2021,
    "area": "Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10530000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Tenaya Therapeutics",
    "ticker": "TNYA",
    "date": "2021-07-29",
    "offer": 15.0,
    "proceeds": 158.1,
    "year": 2021,
    "area": "Gene Therapy/Cardio",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10540000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Candel Therapeutics",
    "ticker": "CADL",
    "date": "2021-07-29",
    "offer": 7.0,
    "proceeds": 62.1,
    "year": 2021,
    "area": "Oncology/Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8870000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Immuneering",
    "ticker": "IMRX",
    "date": "2021-07-29",
    "offer": 15.0,
    "proceeds": 67.5,
    "year": 2021,
    "area": "Oncology/Neuro",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 4500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Rani Therapeutics",
    "ticker": "RANI",
    "date": "2021-07-30",
    "offer": 11.0,
    "proceeds": 73.7,
    "year": 2021,
    "area": "Drug Delivery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6700000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "DiCE Therapeutics",
    "ticker": "DICE",
    "date": "2021-09-15",
    "offer": 17.0,
    "proceeds": 204.0,
    "year": 2021,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Tyra Biosciences",
    "ticker": "TYRA",
    "date": "2021-09-15",
    "offer": 17.0,
    "proceeds": 173.0,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10180000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Exscientia",
    "ticker": "EXAI",
    "date": "2021-10-01",
    "offer": 22.0,
    "proceeds": 304.7,
    "year": 2021,
    "area": "AI/Drug Discovery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13850000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Theseus Pharmaceuticals",
    "ticker": "THRX",
    "date": "2021-10-07",
    "offer": 18.0,
    "proceeds": 160.0,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8890000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cingulate",
    "ticker": "CING",
    "date": "2021-10-07",
    "offer": 9.0,
    "proceeds": 27.0,
    "year": 2021,
    "area": "Neuroscience/ADHD",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cognition Therapeutics",
    "ticker": "CGTX",
    "date": "2021-10-08",
    "offer": 8.0,
    "proceeds": 45.0,
    "year": 2021,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5630000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Pyxis Oncology",
    "ticker": "PYXS",
    "date": "2021-10-08",
    "offer": 16.0,
    "proceeds": 168.0,
    "year": 2021,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Ventyx Biosciences",
    "ticker": "VTYX",
    "date": "2021-10-21",
    "offer": 12.0,
    "proceeds": 151.5,
    "year": 2021,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12630000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CinCor Pharma",
    "ticker": "CINC",
    "date": "2022-01-06",
    "offer": 17.0,
    "proceeds": 193.6,
    "year": 2022,
    "area": "Cardio/Hypertension",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11390000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Amylyx Pharmaceuticals",
    "ticker": "AMLX",
    "date": "2022-01-07",
    "offer": 19.0,
    "proceeds": 190.0,
    "year": 2022,
    "area": "Neuroscience/ALS",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Vigil Neuroscience",
    "ticker": "VIGL",
    "date": "2022-01-11",
    "offer": 14.0,
    "proceeds": 98.0,
    "year": 2022,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Hillstream BioPharma",
    "ticker": "HILS",
    "date": "2022-01-11",
    "offer": 5.0,
    "proceeds": 15.0,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Arcellx",
    "ticker": "ACLX",
    "date": "2022-02-04",
    "offer": 15.0,
    "proceeds": 142.31,
    "year": 2022,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9490000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nuvectis Pharma",
    "ticker": "NVCT",
    "date": "2022-02-04",
    "offer": 5.0,
    "proceeds": 16.0,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3200000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "TC BioPharmaceuticals",
    "ticker": "TCBP",
    "date": "2022-02-11",
    "offer": 5.0,
    "proceeds": 18.0,
    "year": 2022,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Blue Water Vaccines",
    "ticker": "BWV",
    "date": "2022-02-18",
    "offer": 6.0,
    "proceeds": 20.0,
    "year": 2022,
    "area": "Vaccines",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AN2 Therapeutics",
    "ticker": "ANTX",
    "date": "2022-03-24",
    "offer": 15.0,
    "proceeds": 69.0,
    "year": 2022,
    "area": "Infectious Disease",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 4600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Belite Bio",
    "ticker": "BLTE",
    "date": "2022-04-29",
    "offer": 8.0,
    "proceeds": 36.0,
    "year": 2022,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 4500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "HilleVax",
    "ticker": "HLVX",
    "date": "2022-04-29",
    "offer": 17.0,
    "proceeds": 200.0,
    "year": 2022,
    "area": "Vaccines/GI",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11760000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "PepGen",
    "ticker": "PEPG",
    "date": "2022-05-05",
    "offer": 12.0,
    "proceeds": 108.0,
    "year": 2022,
    "area": "Gene Therapy/Neuromuscular",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Okyo Pharma",
    "ticker": "OKYO",
    "date": "2022-05-17",
    "offer": 5.0,
    "proceeds": 2.5,
    "year": 2022,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MAIA Biotechnology",
    "ticker": "MAIA",
    "date": "2022-07-01",
    "offer": 5.0,
    "proceeds": 6.9,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1380000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Third Harmonic Bio",
    "ticker": "THRD",
    "date": "2022-09-14",
    "offer": 17.0,
    "proceeds": 185.3,
    "year": 2022,
    "area": "Immunology/Allergy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10900000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Prime Medicine",
    "ticker": "PRME",
    "date": "2022-10-19",
    "offer": 17.0,
    "proceeds": 175.0,
    "year": 2022,
    "area": "Gene Editing",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10290000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Acrivon Therapeutics",
    "ticker": "ACRV",
    "date": "2022-11-14",
    "offer": 12.5,
    "proceeds": 94.38,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7550000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Coya Therapeutics",
    "ticker": "COYA",
    "date": "2022-12-01",
    "offer": 5.0,
    "proceeds": 5.75,
    "year": 2022,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1150000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cadrenal Therapeutics",
    "ticker": "CVKD",
    "date": "2023-01-20",
    "offer": 4.0,
    "proceeds": 7.0,
    "year": 2023,
    "area": "Hematology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Genelux",
    "ticker": "GNLX",
    "date": "2023-01-26",
    "offer": 5.0,
    "proceeds": 15.0,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Structure Therapeutics",
    "ticker": "GPCR",
    "date": "2023-02-02",
    "offer": 15.0,
    "proceeds": 161.1,
    "year": 2023,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10740000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Mineralys Therapeutics",
    "ticker": "MLYS",
    "date": "2023-02-09",
    "offer": 16.0,
    "proceeds": 220.8,
    "year": 2023,
    "area": "Cardio/Hypertension",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13800000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CytoMed Therapeutics",
    "ticker": "GDTC",
    "date": "2023-04-14",
    "offer": 4.0,
    "proceeds": 9.64,
    "year": 2023,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2410000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Acelyrin",
    "ticker": "SLRN",
    "date": "2023-05-04",
    "offer": 18.0,
    "proceeds": 540.0,
    "year": 2023,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 30000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Azitra",
    "ticker": "AZTR",
    "date": "2023-06-16",
    "offer": 4.0,
    "proceeds": 7.5,
    "year": 2023,
    "area": "Dermatology/Microbiome",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Intensity Therapeutics",
    "ticker": "INTS",
    "date": "2023-06-30",
    "offer": 7.0,
    "proceeds": 19.5,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2790000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "60 Degrees Pharmaceuticals",
    "ticker": "SXTP",
    "date": "2023-07-12",
    "offer": 4.0,
    "proceeds": 7.5,
    "year": 2023,
    "area": "Infectious Disease",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Apogee Therapeutics",
    "ticker": "APGE",
    "date": "2023-07-13",
    "offer": 17.0,
    "proceeds": 300.5,
    "year": 2023,
    "area": "Immunology/Dermatology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17680000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Sagimet Biosciences",
    "ticker": "SGMT",
    "date": "2023-07-13",
    "offer": 16.0,
    "proceeds": 85.0,
    "year": 2023,
    "area": "Metabolic/NASH",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5310000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Turnstone Biologics",
    "ticker": "TSBX",
    "date": "2023-07-20",
    "offer": 12.0,
    "proceeds": 80.0,
    "year": 2023,
    "area": "Cell Therapy/Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Mira Pharmaceuticals",
    "ticker": "MIRA",
    "date": "2023-08-03",
    "offer": 4.0,
    "proceeds": 8.9,
    "year": 2023,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2230000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "RayzeBio",
    "ticker": "RYZB",
    "date": "2023-09-14",
    "offer": 18.0,
    "proceeds": 311.0,
    "year": 2023,
    "area": "Oncology/Radiopharm",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17280000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Neumora Therapeutics",
    "ticker": "NMRA",
    "date": "2023-09-14",
    "offer": 17.0,
    "proceeds": 250.7,
    "year": 2023,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 14750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Adlai Nortye",
    "ticker": "ANL",
    "date": "2023-09-29",
    "offer": 6.5,
    "proceeds": 97.5,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Abivax",
    "ticker": "ABVX",
    "date": "2023-10-19",
    "offer": 11.6,
    "proceeds": 235.8,
    "year": 2023,
    "area": "GI/Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 20330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Lexeo Therapeutics",
    "ticker": "LXEO",
    "date": "2023-11-02",
    "offer": 11.0,
    "proceeds": 100.0,
    "year": 2023,
    "area": "Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9090000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cargo Therapeutics",
    "ticker": "CRGX",
    "date": "2023-11-09",
    "offer": 15.0,
    "proceeds": 281.25,
    "year": 2023,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 18750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CG Oncology",
    "ticker": "CGON",
    "date": "2024-01-25",
    "offer": 19.0,
    "proceeds": 380.0,
    "year": 2024,
    "area": "Oncology/Urology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 20000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "ArriVent BioPharma",
    "ticker": "AVBP",
    "date": "2024-01-25",
    "offer": 18.0,
    "proceeds": 175.0,
    "year": 2024,
    "area": "Oncology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 9720000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Alto Neuroscience",
    "ticker": "ANRO",
    "date": "2024-02-01",
    "offer": 16.0,
    "proceeds": 147.9,
    "year": 2024,
    "area": "Neuroscience/AI",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Fractyl Health",
    "ticker": "GUTS",
    "date": "2024-02-01",
    "offer": 15.0,
    "proceeds": 100.0,
    "year": 2024,
    "area": "Metabolic/Diabetes",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kyverna Therapeutics",
    "ticker": "KYTX",
    "date": "2024-02-07",
    "offer": 22.0,
    "proceeds": 319.0,
    "year": 2024,
    "area": "Cell Therapy/Autoimmune",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 14500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Metagenomi",
    "ticker": "MGX",
    "date": "2024-02-08",
    "offer": 15.0,
    "proceeds": 93.75,
    "year": 2024,
    "area": "Gene Editing",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Telomir Pharmaceuticals",
    "ticker": "TELO",
    "date": "2024-02-29",
    "offer": 4.0,
    "proceeds": 7.0,
    "year": 2024,
    "area": "Anti-aging",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Boundless Bio",
    "ticker": "BOLD",
    "date": "2024-03-27",
    "offer": 16.0,
    "proceeds": 100.0,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Contineum Therapeutics",
    "ticker": "CTNM",
    "date": "2024-04-04",
    "offer": 16.0,
    "proceeds": 110.0,
    "year": 2024,
    "area": "Neuroscience/Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Rapport Therapeutics",
    "ticker": "RAPP",
    "date": "2024-06-06",
    "offer": 17.0,
    "proceeds": 136.0,
    "year": 2024,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Tempus AI",
    "ticker": "TEM",
    "date": "2024-06-13",
    "offer": 37.0,
    "proceeds": 410.7,
    "year": 2024,
    "area": "AI/Diagnostics",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11100000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Alumis",
    "ticker": "ALMS",
    "date": "2024-06-27",
    "offer": 16.0,
    "proceeds": 250.0,
    "year": 2024,
    "area": "Immunology/Dermatology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15630000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Artiva Biotherapeutics",
    "ticker": "ARTV",
    "date": "2024-07-18",
    "offer": 12.0,
    "proceeds": 167.0,
    "year": 2024,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13920000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "OS Therapies",
    "ticker": "OSTX",
    "date": "2024-07-31",
    "offer": 4.0,
    "proceeds": 6.4,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Actuate Therapeutics",
    "ticker": "ACTU",
    "date": "2024-08-12",
    "offer": 5.0,
    "proceeds": 30.0,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Bicara Therapeutics",
    "ticker": "BCAX",
    "date": "2024-09-12",
    "offer": 18.0,
    "proceeds": 362.0,
    "year": 2024,
    "area": "Oncology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 20110000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MBX Biosciences",
    "ticker": "MBX",
    "date": "2024-09-12",
    "offer": 16.0,
    "proceeds": 187.7,
    "year": 2024,
    "area": "Endocrine/Metabolic",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 11730000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zenas BioPharma",
    "ticker": "ZBIO",
    "date": "2024-09-13",
    "offer": 17.0,
    "proceeds": 258.7,
    "year": 2024,
    "area": "Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 15220000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Impact BioMedical",
    "ticker": "IBO",
    "date": "2024-09-16",
    "offer": 5.0,
    "proceeds": 4.5,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 900000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kairos Pharma",
    "ticker": "KAPA",
    "date": "2024-09-16",
    "offer": 4.0,
    "proceeds": 6.2,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1550000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "BioAge Labs",
    "ticker": "BIOA",
    "date": "2024-09-26",
    "offer": 18.0,
    "proceeds": 238.3,
    "year": 2024,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CAMP4 Therapeutics",
    "ticker": "CAMP",
    "date": "2024-10-10",
    "offer": 11.0,
    "proceeds": 75.0,
    "year": 2024,
    "area": "Gene Therapy/RNA",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6820000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Upstream Bio",
    "ticker": "UPB",
    "date": "2024-10-10",
    "offer": 17.0,
    "proceeds": 293.0,
    "year": 2024,
    "area": "Respiratory/Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 17240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Septerna",
    "ticker": "SEPN",
    "date": "2024-10-24",
    "offer": 18.0,
    "proceeds": 331.2,
    "year": 2024,
    "area": "GPCR Therapeutics",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 18400000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Polyrizon",
    "ticker": "PLRZ",
    "date": "2024-10-29",
    "offer": 4.0,
    "proceeds": 4.2,
    "year": 2024,
    "area": "Allergy/ENT",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1050000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Gelteq",
    "ticker": "GELS",
    "date": "2024-10-29",
    "offer": 4.5,
    "proceeds": 5.2,
    "year": 2024,
    "area": "Drug Delivery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1160000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Invizyne Technologies",
    "ticker": "IZTC",
    "date": "2024-11-13",
    "offer": 5.0,
    "proceeds": 15.0,
    "year": 2024,
    "area": "Synthetic Biology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Jupiter Neurosciences",
    "ticker": "JUNS",
    "date": "2024-12-03",
    "offer": 4.0,
    "proceeds": 11.0,
    "year": 2024,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zhengye Biotechnology",
    "ticker": "ZYBT",
    "date": "2025-01-07",
    "offer": 4.0,
    "proceeds": 6.0,
    "year": 2025,
    "area": "Veterinary",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Ascentage Pharma",
    "ticker": "AAPG",
    "date": "2025-01-24",
    "offer": 17.25,
    "proceeds": 126.4,
    "year": 2025,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Maze Therapeutics",
    "ticker": "MAZE",
    "date": "2025-01-30",
    "offer": 16.0,
    "proceeds": 140.0,
    "year": 2025,
    "area": "Nephrology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Metsera",
    "ticker": "MTSR",
    "date": "2025-01-30",
    "offer": 18.0,
    "proceeds": 275.0,
    "year": 2025,
    "area": "Metabolic/Obesity",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 15280000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Sionna Therapeutics",
    "ticker": "SION",
    "date": "2025-02-06",
    "offer": 18.0,
    "proceeds": 191.0,
    "year": 2025,
    "area": "Respiratory/CF",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 10610000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Aardvark Therapeutics",
    "ticker": "AARD",
    "date": "2025-02-12",
    "offer": 16.0,
    "proceeds": 94.2,
    "year": 2025,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5890000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Wellgistics Health",
    "ticker": "WGRX",
    "date": "2025-02-21",
    "offer": 5.0,
    "proceeds": 10.0,
    "year": 2025,
    "area": "Pharma Distribution",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Advanced Biomed",
    "ticker": "ADVB",
    "date": "2025-03-06",
    "offer": 4.0,
    "proceeds": 6.56,
    "year": 2025,
    "area": "Diagnostics",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1640000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cuprina Holdings",
    "ticker": "CUPR",
    "date": "2025-04-11",
    "offer": 4.0,
    "proceeds": 12.0,
    "year": 2025,
    "area": "Wound Care",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Apimeds Pharmaceuticals",
    "ticker": "APUS",
    "date": "2025-05-09",
    "offer": 5.0,
    "proceeds": 13.5,
    "year": 2025,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2700000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nasus Pharma",
    "ticker": "NSRX",
    "date": "2025-08-13",
    "offer": 5.0,
    "proceeds": 10.0,
    "year": 2025,
    "area": "ENT/Nasal",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Curanex Pharmaceuticals",
    "ticker": "CURX",
    "date": "2025-08-26",
    "offer": 4.0,
    "proceeds": 15.0,
    "year": 2025,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "LB Pharmaceuticals",
    "ticker": "LBRX",
    "date": "2025-09-11",
    "offer": 15.0,
    "proceeds": 285.0,
    "year": 2025,
    "area": "Neuroscience/Psych",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 19000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MapLight Therapeutics",
    "ticker": "MPLT",
    "date": "2025-10-27",
    "offer": 17.0,
    "proceeds": 296.3,
    "year": 2025,
    "area": "Neuroscience/Psych",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17430000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Evommune",
    "ticker": "EVMN",
    "date": "2025-11-05",
    "offer": 15.0,
    "proceeds": 150.0,
    "year": 2025,
    "area": "Immunology/Derm",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Aktis Oncology",
    "ticker": "AKTS",
    "date": "2026-01-09",
    "offer": 18.0,
    "proceeds": 318.0,
    "year": 2026,
    "area": "Oncology/Radiopharm",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 17670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Eikon Therapeutics",
    "ticker": "EIKN",
    "date": "2026-02-05",
    "offer": 20.0,
    "proceeds": 381.0,
    "year": 2026,
    "area": "Oncology/Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 19050000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AgomAb Therapeutics",
    "ticker": "AGMB",
    "date": "2026-02-06",
    "offer": 16.0,
    "proceeds": 200.0,
    "year": 2026,
    "area": "GI/Fibrosis",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "SpyGlass Pharma",
    "ticker": "SGP",
    "date": "2026-02-06",
    "offer": 15.0,
    "proceeds": 150.0,
    "year": 2026,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Veradermics",
    "ticker": "MANE",
    "date": "2026-02-06",
    "offer": 17.0,
    "proceeds": 256.3,
    "year": 2026,
    "area": "Dermatology/Hair Loss",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15080000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  }
]
